Speakers and panelists
Guest Speakers
Réjean Hébert, ministre de la Santé et des Services sociaux et ministre Responsable des Aînés
François Meyer, Advisor to the CEO of France HAS, International Relations
Panelists
Reiner Banken, Advisor to the CEO of INESSS
Gaétan Barrette, President, Fédération des médecins spécialistes du Québec
Alain Boisvert, Vice-President, Market Access and Public Affairs, Bristol-Myers Squibb
Canada
Luc Castonguay, Assistant-Deputy Minister, Direction générale de la planification, de la performance et de la qualité, Ministère de la Santé et des Services sociaux du Québec
Diane Côté, President and Chief Executive Officer, Quebec Research and Innovation Consortium in Medical Technologies, MEDTEQ
Véronique Déry, Chief Scientific Advisor, INESSS
Juan Roberto Iglesias, President and Chief Executive Officer of INESSS
Louise Lavergne, President and Chief Executive Officer, Institut de réadaptation en déficience physique de Québec
Paul Lirette, President, GlaxoSmithKline Canada
Teresa Mattarelli, Vice-President and General Manager, Covidien Canada
Marc Rhainds, Medical and Scientific Manager of HTA activities, CHU de Québec
Facilitators
Stéphane Ahern, Internist-intensivist, Maisonneuve-Rosemont Hospital and Chair of INESSS Comité scientifique permanent de l'évaluation des médicaments aux fins d'inscription (CSEMI)
François Bastien, General Manager, Health, Public and Parapublic markets,Telus
Christian Bellemare, Coordinator, Health Technology Assessment Unit,CHUS Hôtel-Dieu
Sylvie Bouchard, Scientific Director, Follow-up and Optimal Use, INESSS
Dan Cooper, Principal Scientific Advisor- Pharmacoeconomics, INESSS
Pierre Dagenais, Director, Directorate of Quality and Method Support, INESSS
Kim Furlong, Director, Government Affairs, Amgen
Benoit Larose, Vice President, MEDEC, Québec
Michelle Laflamme, President and Chief Executive Officer, Émovi
Luigi Lepanto, Director, Health Technology Assessment Unit, CHUM
France Mignault, Director, Government Affairs, Québec, Janssen
Marc Osborne, Director, Government Relations and Health Policy Oncology Division, Hoffman-LaRoche
Gilles Pineau, Coordinator, Oncology Assessment Unit, INESSS
Sophie Rochon, Senior Manager, Patient Access and Health Policy, Pfizer
Jean Rousseau, Business Unit Director, Covidien
Éric St-Gelais, Conseiller en orientation et coordination de la recherche et de l'innovation, MSSS